CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 110 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $321,000 | -69.9% | 38,660 | -72.9% | 0.00% | -100.0% |
| Q3 2019 | $1,065,000 | -47.4% | 142,651 | -21.0% | 0.00% | -50.0% |
| Q2 2019 | $2,026,000 | -43.5% | 180,653 | -45.8% | 0.00% | -50.0% |
| Q1 2019 | $3,584,000 | -21.1% | 333,400 | +10.7% | 0.00% | -20.0% |
| Q4 2018 | $4,542,000 | -45.0% | 301,126 | -32.5% | 0.01% | -28.6% |
| Q3 2018 | $8,255,000 | +2.2% | 446,223 | +26.2% | 0.01% | -12.5% |
| Q2 2018 | $8,081,000 | +383.6% | 353,530 | +501.9% | 0.01% | +300.0% |
| Q1 2018 | $1,671,000 | +44.7% | 58,739 | +7.4% | 0.00% | +100.0% |
| Q4 2017 | $1,155,000 | +16.1% | 54,703 | -0.2% | 0.00% | 0.0% |
| Q3 2017 | $995,000 | – | 54,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |